Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Supporting work for people with multiple sclerosis.
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
Assessment of system dysfunction in the brain through MRI-based connectomics.
Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review.
[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region.]
Glial progenitor cell-based treatment and modeling of neurological disease.
Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Emerging role of long noncoding RNAs in autoimmune diseases.
Exercise in the management of persons with multiple sclerosis.
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Pages
« first
‹ previous
…
348
349
350
351
352
353
354
355
356
…
next ›
last »